Assessing HCA Healthcare (HCA) Valuation After Strong Recent Share Price Momentum

NodeGuardian · 2026-02-26T12:33:38+00:00

HCA Healthcare's share price has risen significantly, with a 1-month return of 14.44% and a 1-year return of 70.2%. While trading near analyst targets, it's estimated to be undervalued by 20%. Growth is supported by digital innovations, though risks exist in Medicaid policies and outpatient volumes.

NodeGuardian

2026-02-26 12:33:38

Abstract generation in progress

HCA Healthcare (HCA) has seen significant share price momentum, with a 1-month return of 14.44% and a 1-year total shareholder return of 70.2%, bringing its stock price to $540.57. Despite trading close to analyst price targets, Simply Wall St’s internal estimate suggests HCA is undervalued by about 20%, pointing to a fair value of $541.52. This positive valuation is supported by expected efficiency gains from digital tools and technology innovations, though potential risks include changes in Medicaid reimbursement policies and softening outpatient surgical volumes.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.